Latest Insider Transactions at Centessa Pharmaceuticals PLC (CNTA)
This section provides a real-time view of insider transactions for Centessa Pharmaceuticals PLC (CNTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Centessa Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Centessa Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
10,000
-2.68%
|
$280,000
$28.96 P/Share
|
|
Dec 08
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
10,000
-5.03%
|
$300,000
$30.0 P/Share
|
|
Dec 08
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.45%
|
$45,000
$9.53 P/Share
|
|
Nov 17
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
40,000
-24.77%
|
$1,120,000
$28.0 P/Share
|
|
Nov 17
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+19.85%
|
$360,000
$9.42 P/Share
|
|
Nov 17
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$162,000
$27.64 P/Share
|
|
Nov 17
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Nov 12
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
40,000
-24.77%
|
$1,040,000
$26.0 P/Share
|
|
Nov 12
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+19.85%
|
$360,000
$9.42 P/Share
|
|
Nov 01
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-0.31%
|
$14,232
$24.9 P/Share
|
|
Oct 27
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
8,000
-3.95%
|
$200,000
$25.0 P/Share
|
|
Oct 27
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.41%
|
$40,000
$8.01 P/Share
|
|
Oct 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$132,000
$22.41 P/Share
|
|
Oct 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Sep 24
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
35,000
-22.36%
|
$840,000
$24.0 P/Share
|
|
Sep 24
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+18.28%
|
$315,000
$9.42 P/Share
|
|
Sep 16
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
8,172
-1.99%
|
$171,612
$21.68 P/Share
|
|
Sep 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$126,000
$21.85 P/Share
|
|
Sep 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Sep 10
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
25,000
-17.06%
|
$550,000
$22.0 P/Share
|
|
Sep 10
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+14.58%
|
$225,000
$9.42 P/Share
|
|
Sep 10
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-15.95%
|
$440,000
$22.0 P/Share
|
|
Sep 10
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.76%
|
$100,000
$5.84 P/Share
|
|
Sep 09
2025
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
24,792
-16.95%
|
$495,840
$20.0 P/Share
|
|
Sep 09
2025
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
24,792
+14.49%
|
$198,336
$8.01 P/Share
|
|
Sep 09
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
7,000
-3.29%
|
$140,000
$20.0 P/Share
|
|
Sep 09
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.3%
|
$40,000
$8.01 P/Share
|
|
Sep 09
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
20,000
-15.95%
|
$400,000
$20.01 P/Share
|
|
Sep 09
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.76%
|
$100,000
$5.84 P/Share
|
|
Aug 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$102,000
$17.23 P/Share
|
|
Aug 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Aug 01
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-0.29%
|
$10,149
$17.17 P/Share
|
|
Jul 29
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
8,322
-3.84%
|
$124,830
$15.23 P/Share
|
|
Jul 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$150,000
$15.56 P/Share
|
|
Jul 25
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
Jul 21
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$825,000
$15.92 P/Share
|
|
Jul 21
2025
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+16.62%
|
$165,000
$3.85 P/Share
|
|
Jul 15
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-5.39%
|
$84,000
$14.93 P/Share
|
|
Jul 15
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+5.11%
|
$30,000
$5.84 P/Share
|
|
Jun 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$130,000
$13.86 P/Share
|
|
Jun 25
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
Jun 24
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
15,000
-6.48%
|
$210,000
$14.0 P/Share
|
|
Jun 24
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.09%
|
$45,000
$3.85 P/Share
|
|
Jun 24
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
12,000
-10.22%
|
$168,000
$14.02 P/Share
|
|
Jun 24
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+9.27%
|
$60,000
$5.84 P/Share
|
|
Jun 20
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$660,000
$12.63 P/Share
|
|
Jun 20
2025
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+16.62%
|
$165,000
$3.85 P/Share
|
|
May 27
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$120,000
$12.82 P/Share
|
|
May 27
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
May 20
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$660,000
$12.71 P/Share
|